155 related articles for article (PubMed ID: 10713709)
1. The cytoprotective aminothiol WR1065 activates p21waf-1 and down regulates cell cycle progression through a p53-dependent pathway.
North S; El-Ghissassi F; Pluquet O; Verhaegh G; Hainaut P
Oncogene; 2000 Feb; 19(9):1206-14. PubMed ID: 10713709
[TBL] [Abstract][Full Text] [Related]
2. Restoration of wild-type conformation and activity of a temperature-sensitive mutant of p53 (p53(V272M)) by the cytoprotective aminothiol WR1065 in the esophageal cancer cell line TE-1.
North S; Pluquet O; Maurici D; El-Ghissassi F; Hainaut P
Mol Carcinog; 2002 Mar; 33(3):181-8. PubMed ID: 11870884
[TBL] [Abstract][Full Text] [Related]
3. Activation of p53 by the cytoprotective aminothiol WR1065: DNA-damage-independent pathway and redox-dependent modulation of p53 DNA-binding activity.
Pluquet O; North S; Richard MJ; Hainaut P
Biochem Pharmacol; 2003 Apr; 65(7):1129-37. PubMed ID: 12663048
[TBL] [Abstract][Full Text] [Related]
4. The cytoprotective aminothiol WR1065 activates p53 through a non-genotoxic signaling pathway involving c-Jun N-terminal kinase.
Pluquet O; North S; Bhoumik A; Dimas K; Ronai Z; Hainaut P
J Biol Chem; 2003 Apr; 278(14):11879-87. PubMed ID: 12531896
[TBL] [Abstract][Full Text] [Related]
5. Aminothiol WR1065 induces differential gene expression in the presence of wild-type p53.
Mann K; Hainaut P
Oncogene; 2005 Jun; 24(24):3964-75. PubMed ID: 15750621
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of wild-type p53 by a dominant negative mutant renders MCF-7 cells resistant to tubulin-binding agent cytotoxicity.
Galmarini CM; Falette N; Tabone E; Levrat C; Britten R; Voorzanger-Rousselot N; Roesch-Gateau O; Vanier-Viornery A; Puisieux A; Dumontet C
Br J Cancer; 2001 Sep; 85(6):902-8. PubMed ID: 11556844
[TBL] [Abstract][Full Text] [Related]
7. Mammalian cell polyamine homeostasis is altered by the radioprotector WR1065.
Mitchell JL; Rupert J; Leyser A; Judd GG
Biochem J; 1998 Oct; 335 ( Pt 2)(Pt 2):329-34. PubMed ID: 9761731
[TBL] [Abstract][Full Text] [Related]
8. Ultraviolet radiation down-regulates expression of the cell-cycle inhibitor p21WAF1/CIP1 in human cancer cells independently of p53.
Wang JA; Fan S; Yuan RQ; Ma YX; Meng Q; Goldberg ID; Rosen EM
Int J Radiat Biol; 1999 Mar; 75(3):301-16. PubMed ID: 10203181
[TBL] [Abstract][Full Text] [Related]
9. Cytostatic activity of cisplatin in the presence of WR2721 and its thiol metabolite WR1065 in OVCAR-3 human ovarian cancer cells as compared to V79 fibroblasts.
Treskes M; Nijtmans L; Fichtinger-Schepman AM; van der Vijgh WJ
Anticancer Res; 1992; 12(6B):2261-5. PubMed ID: 1338281
[TBL] [Abstract][Full Text] [Related]
10. Delayed radioprotection by nuclear transcription factor kappaB -mediated induction of manganese superoxide dismutase in human microvascular endothelial cells after exposure to the free radical scavenger WR1065.
Murley JS; Kataoka Y; Weydert CJ; Oberley LW; Grdina DJ
Free Radic Biol Med; 2006 Mar; 40(6):1004-16. PubMed ID: 16540396
[TBL] [Abstract][Full Text] [Related]
11. Differential radioprotection of cultured human diploid fibroblasts and fibrosarcoma cells by WR1065.
Zhang X; Lai PP; Taylor YC
Int J Radiat Oncol Biol Phys; 1992; 24(4):713-9. PubMed ID: 1429096
[TBL] [Abstract][Full Text] [Related]
12. Radiation-induced p53 and p21WAF-1/CIP1 expression in the murine intestinal epithelium: apoptosis and cell cycle arrest.
Wilson JW; Pritchard DM; Hickman JA; Potten CS
Am J Pathol; 1998 Sep; 153(3):899-909. PubMed ID: 9736038
[TBL] [Abstract][Full Text] [Related]
13. Differential activation of nuclear transcription factor kappaB, gene expression, and proteins by amifostine's free thiol in human microvascular endothelial and glioma cells.
Grdina DJ; Murley JS; Kataoka Y; Calvin DP
Semin Radiat Oncol; 2002 Jan; 12(1 Suppl 1):103-11. PubMed ID: 11917294
[TBL] [Abstract][Full Text] [Related]
14. Effects of tumor necrosis factor-alpha on antimitogenicity and cell cycle-related proteins in MCF-7 cells.
Jeoung DI; Tang B; Sonenberg M
J Biol Chem; 1995 Aug; 270(31):18367-73. PubMed ID: 7629160
[TBL] [Abstract][Full Text] [Related]
15. p53 protein regulates the effects of amifostine on apoptosis, cell cycle progression, and cytoprotection.
Lee EJ; Gerhold M; Palmer MW; Christen RD
Br J Cancer; 2003 Mar; 88(5):754-9. PubMed ID: 12618886
[TBL] [Abstract][Full Text] [Related]
16. The geranylgeranyltransferase-I inhibitor GGTI-298 arrests human tumor cells in G0/G1 and induces p21(WAF1/CIP1/SDI1) in a p53-independent manner.
Vogt A; Sun J; Qian Y; Hamilton AD; Sebti SM
J Biol Chem; 1997 Oct; 272(43):27224-9. PubMed ID: 9341167
[TBL] [Abstract][Full Text] [Related]
17. A peptide fragment of azurin induces a p53-mediated cell cycle arrest in human breast cancer cells.
Yamada T; Mehta RR; Lekmine F; Christov K; King ML; Majumdar D; Shilkaitis A; Green A; Bratescu L; Beattie CW; Das Gupta TK
Mol Cancer Ther; 2009 Oct; 8(10):2947-58. PubMed ID: 19808975
[TBL] [Abstract][Full Text] [Related]
18. F9 embryonal carcinoma cells fail to stop at G1/S boundary of the cell cycle after gamma-irradiation due to p21WAF1/CIP1 degradation.
Malashicheva AB; Kislyakova TV; Aksenov ND; Osipov KA; Pospelov VA
Oncogene; 2000 Aug; 19(34):3858-65. PubMed ID: 10951579
[TBL] [Abstract][Full Text] [Related]
19. The reversal of cisplatin-protein interactions by the modulating agent WR2721 and its metabolites WR1065 and WR33278.
Treskes M; Holwerda U; Nijtmans LG; Pinedo HM; van der Vijgh WJ
Cancer Chemother Pharmacol; 1992; 29(6):467-70. PubMed ID: 1314713
[TBL] [Abstract][Full Text] [Related]
20. Deregulation of p53/p21Cip1/Waf1 pathway contributes to polyploidy and apoptosis of E1A+cHa-ras transformed cells after gamma-irradiation.
Bulavin DV; Tararova ND; Aksenov ND; Pospelov VA; Pospelova TV
Oncogene; 1999 Oct; 18(41):5611-9. PubMed ID: 10523840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
